SGIP1 limits cannabinoid receptor signalling in spinal nociceptive synapses and modulates analgesia during neuroinflammation
The Journal of Physiology · 2026
DOI: 10.1113/jp291830 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physiology, 2026. Verfasst von Denisa Dresslerova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic. Hauptthemen laut MEDLINE: Synapses, Receptor, Cannabinoid, CB1, Neuroinflammatory Diseases, Nociceptors. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Grant Agency of the Czech Republic, Ministry of Education, Youth and Sports, Institutional support.
Abstract (Originalsprache)
The endocannabinoid system is important for pain modulation, whereas its utilization for analgesia is restricted due to the limited efficacy of cannabinoids and side effects. Cannabinoid receptor 1 (CB 1 ) in the spinal dorsal horn provides presynaptic inhibition of nociceptive neurotransmission. CB 1 regulatory protein, SH3‐containing GRB2‐like protein 3‐interacting protein 1 (SGIP1), controls its functional availability, while its role in pain modulation remains poorly understood. We examined the role of SGIP1 in nociceptive signalling under control and inflammatory conditions, using behavioural tests, patch‐clamp recordings in spinal cord slices and calcium imaging of dorsal root ganglion (DRG) neurons. SGIP1 knockout (KO) mice of both sexes showed a selective reduction in heat sensitivity, with no change in mechanical withdrawal threshold. Following carrageenan‐induced inflammation, both wild‐type (WT) and KO mice developed mechanical allodynia, whereas thermal hyperalgesia in KO mice reached only the control values of WT mice. Intrathecal application of cannabinoid agonist WIN55,212‐2 produced analgesia in both WT and KO mice, with enhanced effect of the lower dose (5 µg vs . 10 µg) in KO animals. WIN55,212‐2 (1 µM) in slices from inflamed SGIP1 KO mice induced significantly greater reduction in miniature excitatory postsynaptic current (mEPSC) frequency, without amplitude change, indicating enhanced presynaptic inhibition in KO mice. These enhanced inhibitory effects of WIN55,212‐2 in KO mice after inflammation were further demonstrated in DRG cultured neurons. Our results establish SGIP1 as a state‐dependent negative modulator of CB 1 function and identify SGIP1–CB 1 interaction as a candidate target for selective enhancement of cannabinoid analgesia under inflammatory pain conditions. image Key points SGIP1 deletion reduced basal heat sensitivity in mice of both sexes without altering mechanical threshold, suggesting a sex‐independent role in thermal nociception. Inflammation increased mechanical and thermal sensitivity in both SGIP1 KO and WT mice, whereas the increased thermal sensitivity of KO reached only the baseline levels of WT mice. Intrathecal cannabinoid agonist WIN55,212‐2 produced analgesia in both genotypes, with a bigger effect of the lower dose (5 vs . 10 µg) in SGIP1 KO mice. WIN55,212‐2 induced strong inhibition of miniature excitatory postsynaptic current (mEPSC) frequency in dorsal horn neurons that was selectively potentiated by SGIP1 deletion under inflammatory, but not control, conditions, consistent with a presynaptic locus of action. These effects were further confirmed by calcium imaging in DRG cultured neurons. SGIP1 acts as an inflammation‐dependent presynaptic CB 1 modulator of spinal nociceptive transmission, positioning the SGIP1–CB 1 interaction as a candidate target for selective enhancement of cannabinoid analgesia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Pain Research, Institute of Physiology of the Czech Academy of Sciences, Prague, Czech Republic.
ORCID-Profile: Denisa Dresslerova, Monica Pontearso, Anirban Bhattacharyya, Jakub Slepicka, Diana Spicarova
Förderung
- Grant Agency of the Czech Republic
- Ministry of Education, Youth and Sports
- Institutional support
- European Union Next Generation EU
- Grantová Agentura České Republiky
- Ministerstvo Školství, Mládeže a Tělovýchovy
Zitieren
APA
Dresslerova, D., Pontearso, M., Muzik, D., Bhattacharyya, A., Slepicka, J., Vasconcelos, D., Palecek, J., & Spicarova, D. (2026). SGIP1 limits cannabinoid receptor signalling in spinal nociceptive synapses and modulates analgesia during neuroinflammation. The Journal of Physiology. https://doi.org/10.1113/jp291830
Vancouver
Dresslerova D, Pontearso M, Muzik D, Bhattacharyya A, Slepicka J, Vasconcelos D, et al. SGIP1 limits cannabinoid receptor signalling in spinal nociceptive synapses and modulates analgesia during neuroinflammation. The Journal of Physiology. 2026. doi:10.1113/jp291830
BibTeX
@article{Dresslerova2026,
author = {Dresslerova, Denisa and Pontearso, Monica and Muzik, David and Bhattacharyya, Anirban and Slepicka, Jakub and Vasconcelos, Daniel and Palecek, Jiri and Spicarova, Diana},
title = {SGIP1 limits cannabinoid receptor signalling in spinal nociceptive synapses and modulates analgesia during neuroinflammation},
journal = {The Journal of Physiology},
year = {2026},
doi = {10.1113/jp291830}
}
EUVIMED